Literature DB >> 21914419

Giant dedifferentiated retroperitoneal liposarcoma.

Mohammed Amir1, Saeed Akhtar, Minhal Pervaiz, Athar Khawaja, Imran Ahmad.   

Abstract

A 72 years old lady presented with a gradually increasing abdominal mass for the last 25 years, with more rapid increase in the last 05 years. Examination revealed a large mass spanning the whole abdomen. CAT scan revealed a huge retroperitoneal tumour, with tortuous ureters passing through the tumour and three tiny nodules in the right lung field. A subtotal piecemeal excision of the tumour was done after stenting the ureters with single J stents. The excised tumour mass weighed 46 Kg. The patient had a prolonged ileus that recovered in 5 days. Histopathology revealed the mass to be dedifferentiated liposarcoma. The patient and the family were satisfied with the short-term outcome of the surgery. She was ambulating with little support and was able to manage her daily affairs.

Entities:  

Mesh:

Year:  2011        PMID: 21914419     DOI: 09.2011/JCPSP.569571

Source DB:  PubMed          Journal:  J Coll Physicians Surg Pak        ISSN: 1022-386X            Impact factor:   0.711


  3 in total

Review 1.  Clinicopathological characteristics and experience in the treatment of giant retroperitoneal liposarcoma: A case report and review of the literature.

Authors:  Xiangyu Zeng; Weizhen Liu; Xiuli Wu; Jinbo Gao; Peng Zhang; Xiaoming Shuai; Kaixiong Tao
Journal:  Cancer Biol Ther       Date:  2017-07-31       Impact factor: 4.742

2.  Linc00423 as a tumor suppressor in retroperitoneal liposarcoma via activing MAPK signaling pathway through destabilizing of NFATC3.

Authors:  Yong Zhang; Hanxing Tong; Junyi He; Yebo Shao; Xi Guo; Rongyuan Zhuang; Jue Yang; Ju Liu; Yuqin Ding; Wenshuai Liu; Weiqi Lu; Yuhong Zhou
Journal:  Cell Death Dis       Date:  2019-06-03       Impact factor: 8.469

3.  A recurrent giant retroperitoneal myxoid liposarcoma: a case report and literature review.

Authors:  Shanshan Guo; Yingying Xu; Feng Qian; Jingfan Ma; Shaojun Wang; Ping Chen; Liang Zong
Journal:  Transl Cancer Res       Date:  2019-11       Impact factor: 1.241

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.